HDIM
EW icon

Hanson & Doremus Investment Management’s Edwards Lifesciences EW Stock Holding History

Hanson & Doremus Investment Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28K Hold
312
– – ﹤0.01% 362
2026
Q1 		$25K Buy
+312
New +$25.7K ﹤0.01% 390
2024
Q2 		– Sell
-51
Closed -$5K – 461
2024
Q1 		$5K Buy
+51
New +$4.28K ﹤0.01% 439
2023
Q2 		– Sell
-202
Closed -$17K – 453
2023
Q1 		$17K Buy
+202
New +$15.9K ﹤0.01% 387

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Hanson & Doremus Investment Management's EW Position: Q2 2026 in Review

Hanson & Doremus Investment Management held its Edwards Lifesciences (EW) position steady in Q2 2026 at 312 shares worth $28K. The position accounts for ﹤0.01% of the portfolio, ranked #362.

Hanson & Doremus Investment Management first reported a position in EW in Q1 2023 and has held it in 4 quarters since. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Hanson & Doremus Investment Management held 312 shares of Edwards Lifesciences worth $28K as of Q2 2026.
  • Hanson & Doremus Investment Management left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of Hanson & Doremus Investment Management's portfolio in Q2 2026, its #362 holding.
  • Hanson & Doremus Investment Management first reported a position in Edwards Lifesciences in Q1 2023 and has held it in 4 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.